Recent studies have implicated LIF-LIFR signaling in playing a key role in tumor growth, progression, metastasis, stemness and therapy resistance; the LIF-LIFR axis may be considered as a promising clinical target for cancer therapy [51]. This evidence concerns the gene LIF and neoplasm.